28 results
8-K
EX-10.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
. In the event of any controversy, claim or dispute between the Parties arising out of or in any manner relating to this Agreement, the prevailing … Party in any action brought to resolve such controversy, claim or dispute shall be entitled to recover reasonable attorney’s fees and costs.
13
8-K
EX-10.6
m6o623y6i9oi1agog9
22 Nov 23
Entry into a Material Definitive Agreement
1:55pm
10-12G/A
ibysod7j1fxhzkh0wc97
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
uydvsn4l1 cxbaw5yon
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
3we0w0v38dqaoobejb9
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
tolwapf
9 Sep 22
Registration of securities
9:46pm
S-1
7cajr7ul6lxzczbd3n1t
9 Sep 22
IPO registration
5:13pm